Clinical Trial Update: FCI Effectiveness in NAFLD Stratification [NA]

View source ↗

Summary

The clinical trial NCT05827432 evaluating FCI effectiveness in stratifying Non-Alcoholic Fatty Liver Disease has been withdrawn by the sponsor NHS Grampian.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: NHS Grampian | Conditions: Non-Alcoholic Fatty Liver Disease | NA | Status: WITHDRAWN